跳至主要内容
临床试验/NCT04656665
NCT04656665Unknown4 期

The Effectiveness of Low-dose Aspirin on Preventing Pre-eclampsia in High-risks Pregnant Women

The Third Affiliated Hospital of Guangzhou Medical University0 个研究点目标入组 600 人开始时间: 2021年3月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
600
主要终点
Incidence of pre-eclampsia

研究概览

简要总结

This study will explore the effectiveness of low-dose aspirin on preventing pre-eclampsia in high-risks pregnant women by comparing the incidence of pre-eclampsia and pregnancy outcomes.

详细描述

Currently,low-dose aspirin is a commonly used drug to prevent pre-eclampsia. Many guidelines recommend starting low-dose aspirin in early pregnancy in high-risks pregnant women. However, the applicable population and use method of aspirin are still controversial in clinical practice. This study will explore the effectiveness and use method of low-dose aspirin by comparing the incidence of pre-eclampsia and pregnancy outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age between 18-55 years
  • Gestational age between 12-20 weeks of pregnancy
  • High risk of developing pre-eclampsia
  • At least one of the following risk factors: Pre-eclampsia in a previous pregnancy , Multiple pregnancy,Diabetes Mellitus(Type 1 or 2), Chronic Hypertension,Renal disease, Autoimmune disease.
  • At least two of the following risk factors: Primiparity,Pre-pregnancy Body Mass Index ≥28kg/m2, Age ≥35 years, Family members have a history of pre-eclampsia.
  • Maternal informed conset obtained

排除标准

  • Contraindication to aspirin therapy (including but not limited to allergy and high bleeding risk)
  • Patient with known intention to terminate pregnancy
  • Fetal abnormalities detected (including but not limited to major fetal malformation and FGR)
  • Severe heart, liver, renal disease who can not burden the experiment
  • Alcohol and drug abuse
  • Being in another drug experiment within 3 months

研究组 & 干预措施

75mg

Experimental

Take 75mg of aspirin daily in tihis group

干预措施: Aspirin (Drug)

100mg

Active Comparator

Take 100mg of aspirin daily in this group

干预措施: Aspirin (Drug)

结局指标

主要结局

Incidence of pre-eclampsia

时间窗: 1 year

Record the number of pre-eclampsia in each group and compare whether there are statistical differences in the incidence of each group

次要结局

  • Postpartum hemorrhage(1 year)
  • Preterm birth(1 year)
  • Placental abruption 4/5000 Placental abruption(1 year)
  • Fetal growth restriction(1 year)

研究者

发起方
The Third Affiliated Hospital of Guangzhou Medical University
申办方类型
Other
责任方
Sponsor

相似试验